Myriad Genetics
MYGN
MYGN
213 hedge funds and large institutions have $2.55B invested in Myriad Genetics in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 78 increasing their positions, 65 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 201 → 213 (+12)
3.57% more ownership
Funds ownership: 97.98% → 101.55% (+3.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
213
Holding in Top 10
1
Calls
$7.61M
Puts
$4.29M
Top Buyers
| 1 | +$72.3M | |
| 2 | +$24.2M | |
| 3 | +$19.1M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$17.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$9.89M |
Top Sellers
| 1 | -$8.29M | |
| 2 | -$8.07M | |
| 3 | -$7.78M | |
| 4 |
Millennium Management
New York
|
-$7.55M |
| 5 |
D.E. Shaw & Co
New York
|
-$7.55M |